Table 2.
Pathological stage | |||||||
---|---|---|---|---|---|---|---|
|
|
IA |
IB |
IIA |
IIB |
IIIA |
IIIB |
Clinical stage |
IA |
23 |
2 |
8 |
1(T1→T2 N0→N1) |
1 |
1 |
|
(T1→T2) |
(N0→N1) |
|
(N0→N2) |
(T1→T4) |
||
IB |
1 |
6 |
1 |
1 |
3 (T2→T3,N0→N1) |
|
|
(N1→N0) |
|
(N0→N1) |
(N0→N1) |
(N0→N2) |
|
||
(T2→T3,N0→N1) | |||||||
IIA |
1 |
|
4 |
|
|
1 |
|
(N1→N0) |
|
|
|
|
(T1→T4 N1→N2) |
||
IIB |
|
|
|
3 |
|
1 |
|
(T2→T4) | |||||||
IIIA |
|
|
|
|
7 |
1 |
|
(T2→T4) | |||||||
IIIB | 3 |
Parentheses indicated the differences in N- and T-factors between clinical and pathological stages in mismatched patients (n = 23).